Research Topics
| Eberechukwu OnukwughaSummaryAffiliation: University of Maryland Country: USA Publications
| Collaborators
|
Detail Information
Publications
Reasons for discharges against medical advice: a qualitative studyEberechukwu Onukwugha
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
Qual Saf Health Care 19:420-4. 2010..The objective of this study is to identify the reasons for DAMA based on patient and multicategory provider focus-group interviews (FGIs)...
Racial differences in hospital discharge disposition among stroke patients in MarylandEbere Onukwugha
University of Maryland, School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, MD 21201, USA
Med Decis Making 27:233-42. 2007..The objective of this retrospective study was to assess the evidence for racial differences in discharge disposition among patients hospitalized for stroke...- Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancerEberechukwu Onukwugha
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
Urology 77:1088-95. 2011..The role of specialists in the management of advanced PCa is evolving in response to positive chemotherapy trials of PCa... - Readmissions after unauthorized discharges in the cardiovascular settingEberechukwu Onukwugha
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Med Care 49:215-24. 2011.... - Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular diseaseEbere Chukwu Onukwugha
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Ethn Dis 19:172-8. 2009..Disparities in discharges AMA have not been examined among patients with cardiovascular disease, nor has the moderating role of hospital quality been studied... - Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care systemEbere Onukwugha
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
Value Health 11:980-8. 2008..To identify a cost-saving subset of criteria for the use of tiotropium at a Veterans Affairs Medical Center based on a cost-effectiveness analysis with ipratropium as the comparator... - The total economic burden of overactive bladder in the United States: a disease-specific approachEbere Onukwugha
Department of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
Am J Manag Care 15:S90-7. 2009..To employ results from a recent US population-based survey to calculate disease-specific total costs of overactive bladder (OAB)... - The dual impact of rehabilitation admission and race/ethnicity on discharges against medical adviceE Onukwugha
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
NeuroRehabilitation 24:67-74. 2009..However, the predictive effect of an admission for rehabilitative care has not been examined in an inpatient stroke population, nor has the impact of race/ethnicity on this relationship been reported... - Health disparities in staging of SEER-medicare prostate cancer patients in the United StatesC Daniel Mullins
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
Urology 76:566-72. 2010..To examine whether race or age disparities affected the odds of being staged among prostate cancer (PC) patients. Accurate staging is critical for determining treatment for PC... - Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysisMyra Schneider
School of Pharmacy, University of Maryland Baltimore, Maryland, USA
J Am Geriatr Soc 59:637-46. 2011..To investigate the survival benefit associated with chemotherapy receipt in older women with estrogen receptor-negative (ER-) Stage IV breast cancer... - Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancerIlene H Zuckerman
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
J Am Geriatr Soc 57:1403-10. 2009..To estimate the modifying effect of age on the survival benefit associated with adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer... - Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluationAmy J Davidoff
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Med Care 47:1229-36. 2009..Recent healthcare system and environmental changes may have reduced treatment gaps... 
A sustainable strategy to prevent misuse of antibiotics for acute respiratory infectionsGail B Rattinger
Veterans Affairs Maryland Health Care System, Baltimore, MD, USA
PLoS ONE 7:e51147. 2012..Could a clinical decision support system (CDSS), interposed at the time of electronic prescription, adjust antibiotics utilization toward consensus treatment guidelines for ARI?..- Racial variation in the cost-effectiveness of chemotherapy for prostate cancerMichael Grabner
University of Maryland School of Pharmacy, Baltimore, MD and University of Georgia College of Pharmacy, Athens, GA
J Oncol Pract 7:e16s-24s. 2011.... - Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patientsC Daniel Mullins
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
Cancer 118:3173-81. 2012..Whether the benefits of these agents justify the additional costs for elderly Medicare recipients is particularly policy relevant after US health care reform... - The potential impact of comparative effectiveness research on the health of minority populationsC Daniel Mullins
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
Health Aff (Millwood) 29:2098-104. 2010..We also recommend the increased recruitment of minorities for clinical trials, and such measures as using community health workers to translate research results in ways that will increase their relevance to minority patients... - Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the USJohn F P Bridges
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
Pharmacoeconomics 28:175-84. 2010..We conclude that while a threshold may be needed to interpret the results of a cost-effectiveness analysis, that threshold must vary across payers, populations and even procedures... - Racial variation in the cost-effectiveness of chemotherapy for prostate cancerMichael Grabner
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Am J Manag Care 17:e151-9. 2011.... - Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrelEmily S Reese
School of Pharmacy, University of Maryland, Baltimore, Maryland, USA
Pharmacotherapy 32:323-32. 2012..To estimate the cost-effectiveness of genotype-guided selection of antiplatelet therapy compared with selecting clopidogrel or prasugrel irrespective of genotype...